Why Are Nasdaq, S&P 500 Futures Falling Premarket? NVDA, BABA, PSKY, SLS, AAOI, SPCX, RKLB Stocks In Focus
U.S. stock futures fell Monday due to new Iran sanctions and U.S.-Canada trade tensions. Gold rose to $4,700/oz, while crude futures dropped 2% to $85.23/bbl. Nvidia (NVDA) plans hardware price hikes and a licensing deal. Alibaba (BABA) shares dropped 4% after a $10.2B equity raise. Applied Optoelectronics (AAOI) fell 13% on a $600M equity offering. SpaceX (SPCX) faces a 'Sell' rating from DZ Bank. Sellas Life Sciences (SLS) gained 2% on trial progress. Eli Lilly (LLY) launched its weight-manage
How this was made
The 30-second read
Why it matters
The article aggregates several first‑report events that could drive short‑term volatility across tech, biotech, and aerospace stocks.
Market read
The mix of new capital raises, price hikes, and trial milestones creates a nuanced risk/reward landscape for traders.
What to watch
Potential downstream effects of US‑Iran sanctions on energy prices and broader market risk appetite are not fully priced in.
Background
Futures fell as geopolitical and trade tensions rose; multiple companies disclosed fresh capital actions and operational updates.
Ticker impact
NVDA told customers it will raise hardware prices by over 15% due to higher memory costs ahead of its earnings report.
Short‑term downside risk until earnings clarify impact.
Price hike news is fresh but magnitude uncertain; earnings will confirm market reaction.
BABA announced a $10.2 billion equity raise to fund AI infrastructure, causing a 4% pre‑market drop.
Further downside pressure expected in the short term.
The raise is a material capital event disclosed for the first time.
MRVL is highlighted for its agreement with Google and upcoming earnings, keeping it on retail radar.
Limited immediate impact.
Only a forward‑looking statement, no fresh disclosure.
AAOI filed a $600 million at‑the‑market equity offering to fund AI data‑center optical transceiver expansion, sending the stock down 13% pre‑market.
Short‑term downside expected.
First report of a sizable ATM offering.
SpaceX plans to wind down the Falcon program to focus on Starship, with DZ Bank issuing a sell recommendation and a $100 price target.
Limited direct impact on SPCX (private) but market sentiment could shift.
SpaceX is private; the news is about strategy, not a tradable ticker.
RKLB began flight‑like testing of its “Hungry Hippo” fairing mechanism ahead of the Neutron rocket debut.
Potential modest upside if test results are positive.
First public update on a key development.
SLS shares rose 2% as traders noted its REGAL Phase 3 AML trial may have reached the 80th event needed for final analysis.
Small upside as trial milestones are confirmed.
New trial milestone disclosed.
PSKY’s CEO is set to meet California’s Attorney General regarding an antitrust lawsuit tied to its proposed Warner Bros. Discovery deal.
Unclear impact until outcome is known.
Only a scheduled meeting, no new resolution.
Market effects
AI‑related hardware and biotech sectors face mixed news: price hikes and dilution for hardware, trial progress for biotech.
US futures dip; Canadian trade tensions add risk to North‑American markets.
Sanctions on Iran and US‑Canada tariff war could affect energy and commodity markets globally.
Counterpoint
Despite dilution and price hikes, AI demand may sustain higher valuations; investors could view the news as short‑term noise.
Key entities
- CompanyNVDA
Nvidia Corp.
- CompanyBABA
Alibaba Group Holding Ltd.
- CompanyAAOI
Applied Optoelectronics Inc.
- CompanySLS
Sellas Life Sciences Inc.
